Indiana Trust & Investment Management’s Pacira BioSciences PCRX Stock Holding History

Indiana Trust & Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.3K	Hold	760	–	–	0.01%	368
2026 Q1	$17.2K	Hold	760	–	–	0.01%	370
2025 Q4	$19.7K	Hold	760	–	–	0.01%	352
2025 Q3	$19.6K	Hold	760	–	–	0.01%	349
2025 Q2	$18.2K	Hold	760	–	–	0.01%	350
2025 Q1	$18.9K	Hold	760	–	–	0.01%	347
2024 Q4	$14.3K	Hold	760	–	–	﹤0.01%	370
2024 Q3	$11.4K	Hold	760	–	–	﹤0.01%	395
2024 Q2	$21.7K	Hold	760	–	–	0.01%	330
2024 Q1	$22.2K	Hold	760	–	–	0.01%	331
2023 Q4	$25.6K	Hold	760	–	–	0.01%	305
2023 Q3	$23.3K	Buy	+760	New	+$27.4K	0.01%	311

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Indiana Trust & Investment Management's PCRX Position: Q2 2026 in Review

Indiana Trust & Investment Management held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 760 shares worth $19.3K. The position accounts for 0.01% of the portfolio, ranked #368.

Indiana Trust & Investment Management first reported a position in PCRX in Q3 2023 and has held it in 12 quarters since. The position peaked at $25.6K in Q4 2023. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Indiana Trust & Investment Management held 760 shares of Pacira BioSciences worth $19.3K as of Q2 2026.
Indiana Trust & Investment Management left its Pacira BioSciences share count unchanged in Q2 2026.
Pacira BioSciences made up 0.01% of Indiana Trust & Investment Management's portfolio in Q2 2026, its #368 holding.
Indiana Trust & Investment Management first reported a position in Pacira BioSciences in Q3 2023 and has held it in 12 quarters since.
Indiana Trust & Investment Management's Pacira BioSciences position peaked at $25.6K in Q4 2023.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Indiana Trust & Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.